Literature DB >> 20085596

Practical prebiotics, probiotics and synbiotics for allergists: how useful are they?

H Johannsen1, S L Prescott.   

Abstract

With the advent of the hygiene hypothesis, probiotics have provided an avenue of hope in curbing the allergic epidemic. The initial enthusiasm has been tempered by recognition of the inherent complexities of this approach. This review examines the current clinical evidence and practical issues in using probiotics and related products, for the prevention and treatment of allergic disease. So far, probiotics have shown more promise, albeit limited, in the primary prevention of allergic disease rather than in the treatment of established disease. These effects have largely been limited to the prevention of early childhood conditions such as eczema, with no consistent effects on other allergic outcomes. There is emerging evidence that clinical effects may be strain specific, but again these findings have been inconsistent. While there have been several meta-analyses to examine probiotics in both the prevention and the treatment of allergic disease, these have been hampered by significant heterogeneity between studies, including wide variations in the strains used, the methods and timing of administration and the age and assessment of allergic outcomes. In any case, these have also become outdated by a series of new studies published in the last year. Although it is not yet clear exactly how the growing number of new studies will modify the results of meta-analyses, it is likely that these will add yet further heterogeneity that will continue to make interpretation of pooled data difficult. At this stage, the effects of prebiotics, synbiotics and postbiotics are even less clear. Thus, while there is little doubt that microbiota modulate immune development and can prevent the allergic phenotype, the optimal way of achieving this is far from clear. Given the current level of evidence, it is not appropriate to recommend prebiotics/probiotics/synbiotics or postbiotics as a part of standard therapy or for the prevention of any allergic conditions. Further studies are needed to address the growing speculation that supplementation with a single probiotic strain may be oversimplistic and that approaches that have a more global effect on colonization may be warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20085596     DOI: 10.1111/j.1365-2222.2009.03368.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  12 in total

Review 1.  Developments in the field of allergy in 2009 through the eyes of Clinical and Experimental Allergy.

Authors:  H W Chu; C M Lloyd; W Karmaus; P Maestrelli; P Mason; G Salcedo; J Thaikoottathil; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-11       Impact factor: 5.018

Review 2.  Gene-environment interactions in chronic inflammatory disease.

Authors:  Harald Renz; Erika von Mutius; Per Brandtzaeg; William O Cookson; Ingo B Autenrieth; Dirk Haller
Journal:  Nat Immunol       Date:  2011-04       Impact factor: 25.606

3.  Asthma and allergy: the early beginnings.

Authors:  Catherine Hawrylowicz; Kimuli Ryanna
Journal:  Nat Med       Date:  2010-03       Impact factor: 53.440

4.  Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.

Authors:  J O Fleming; A Isaak; J E Lee; C C Luzzio; M D Carrithers; T D Cook; A S Field; J Boland; Z Fabry
Journal:  Mult Scler       Date:  2011-03-03       Impact factor: 6.312

5.  Synbiotics in Children with Cow's Milk Allergy: A Randomized Controlled Trial.

Authors:  Hamid Ahanchian; Zahra Nouri; Seyed-Ali Jafari; Toktam Moghiman; Mohammad-Hadi Amirian; Atefeh Ezzati; Hamid-Reza Kianifar
Journal:  Iran J Pediatr       Date:  2014-01-03       Impact factor: 0.364

6.  The effects of environmental pollution and climate change on allergic diseases.

Authors:  Bernard Yu-Hor Thong
Journal:  Asia Pac Allergy       Date:  2013-07-30

Review 7.  Probiotics and food allergy.

Authors:  Anna Maria Castellazzi; Chiara Valsecchi; Silvia Caimmi; Amelia Licari; Alessia Marseglia; Maria Chiara Leoni; Davide Caimmi; Michele Miraglia del Giudice; Salvatore Leonardi; Mario La Rosa; Gian Luigi Marseglia
Journal:  Ital J Pediatr       Date:  2013-07-29       Impact factor: 2.638

8.  Probiotics and atopic dermatitis in children.

Authors:  Fabio Meneghin; Valentina Fabiano; Chiara Mameli; Gian Vincenzo Zuccotti
Journal:  Pharmaceuticals (Basel)       Date:  2012-07-06

9.  Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma.

Authors:  Seil Sagar; Mary E Morgan; Si Chen; Arjan P Vos; Johan Garssen; Jeroen van Bergenhenegouwen; Louis Boon; Niki A Georgiou; Aletta D Kraneveld; Gert Folkerts
Journal:  Respir Res       Date:  2014-04-16

10.  The biodiversity hypothesis and allergic disease: world allergy organization position statement.

Authors:  Tari Haahtela; Stephen Holgate; Ruby Pawankar; Cezmi A Akdis; Suwat Benjaponpitak; Luis Caraballo; Jeffrey Demain; Jay Portnoy; Leena von Hertzen
Journal:  World Allergy Organ J       Date:  2013-01-31       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.